197 related articles for article (PubMed ID: 16431925)
21. Phosphorylation and recruitment of Syk by immunoreceptor tyrosine-based activation motif-based phosphorylation of tamalin.
Hirose M; Kitano J; Nakajima Y; Moriyoshi K; Yanagi S; Yamamura H; Muto T; Jingami H; Nakanishi S
J Biol Chem; 2004 Jul; 279(31):32308-15. PubMed ID: 15173175
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase.
Chen SY; Lu J; Shih YC; Tsai CH
J Virol; 2002 Sep; 76(18):9556-61. PubMed ID: 12186939
[TBL] [Abstract][Full Text] [Related]
23. PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins.
Ikeda M; Ikeda A; Longnecker R
J Virol; 2001 Jun; 75(12):5711-8. PubMed ID: 11356981
[TBL] [Abstract][Full Text] [Related]
24. The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo.
Merchant M; Caldwell RG; Longnecker R
J Virol; 2000 Oct; 74(19):9115-24. PubMed ID: 10982358
[TBL] [Abstract][Full Text] [Related]
25. Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma.
Cen O; Kannan K; Huck Sappal J; Yu J; Zhang M; Arikan M; Ucur A; Ustek D; Cen Y; Gordon L; Longnecker R
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135222
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus latent membrane protein 2 effects on epithelial acinus development reveal distinct requirements for the PY and YEEA motifs.
Fotheringham JA; Raab-Traub N
J Virol; 2013 Dec; 87(24):13803-15. PubMed ID: 24109232
[TBL] [Abstract][Full Text] [Related]
27. Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.
Rovedo M; Longnecker R
J Virol; 2007 Jan; 81(1):84-94. PubMed ID: 17035319
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction.
Miller CL; Lee JH; Kieff E; Burkhardt AL; Bolen JB; Longnecker R
Infect Agents Dis; 1994; 3(2-3):128-36. PubMed ID: 7812651
[TBL] [Abstract][Full Text] [Related]
29. The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling.
Ikeda M; Longnecker R
Virology; 2009 Mar; 385(1):183-91. PubMed ID: 19081591
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelial cells.
Scholle F; Longnecker R; Raab-Traub N
Virology; 2001 Dec; 291(2):208-14. PubMed ID: 11878890
[TBL] [Abstract][Full Text] [Related]
31. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus LMP2A utilizes Syk and PI3K to activate NF-κB in B-cell lymphomas to increase MIP-1α production.
Incrocci R; McAloon J; Montesano M; Bardahl J; Vagvala S; Stone A; Swanson-Mungerson M
J Med Virol; 2019 May; 91(5):845-855. PubMed ID: 30609049
[TBL] [Abstract][Full Text] [Related]
33. Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors.
Neuhaus B; Bühren S; Böck B; Alves F; Vogel WF; Kiefer F
Cell Mol Life Sci; 2011 Nov; 68(22):3757-70. PubMed ID: 21499918
[TBL] [Abstract][Full Text] [Related]
34. The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1.
Dawson CW; George JH; Blake SM; Longnecker R; Young LS
Virology; 2001 Oct; 289(2):192-207. PubMed ID: 11689042
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiation.
Fotheringham JA; Mazzucca S; Raab-Traub N
Oncogene; 2010 Jul; 29(30):4287-96. PubMed ID: 20498633
[TBL] [Abstract][Full Text] [Related]
36. Differential dephosphorylation of the FcRgamma immunoreceptor tyrosine-based activation motif tyrosines with dissimilar potential for activating Syk.
Yamashita T; Suzuki R; Backlund PS; Yamashita Y; Yergey AL; Rivera J
J Biol Chem; 2008 Oct; 283(42):28584-94. PubMed ID: 18715866
[TBL] [Abstract][Full Text] [Related]
37. Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A.
Fish K; Comoglio F; Shaffer AL; Ji Y; Pan KT; Scheich S; Oellerich A; Doebele C; Ikeda M; Schaller SJ; Nguyen H; Muppidi J; Wright GW; Urlaub H; Serve H; Staudt LM; Longnecker R; Oellerich T
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26318-26327. PubMed ID: 33020271
[TBL] [Abstract][Full Text] [Related]
38. Sequence variations of latent membrane protein 2A in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.
Han J; Chen JN; Zhang ZG; Li HG; Ding YG; Du H; Shao CK
PLoS One; 2012; 7(3):e34276. PubMed ID: 22470549
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.
Lin JH; Lin JY; Chou YC; Chen MR; Yeh TH; Lin CW; Lin SJ; Tsai CH
Blood; 2015 Apr; 125(14):2228-38. PubMed ID: 25631773
[TBL] [Abstract][Full Text] [Related]
40. Conformational changes induced in the protein tyrosine kinase p72syk by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides.
Kimura T; Sakamoto H; Appella E; Siraganian RP
Mol Cell Biol; 1996 Apr; 16(4):1471-8. PubMed ID: 8657120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
